Molecule Details
| InChIKey | QSKQVZWVLOIIEV-NSHDSACASA-N |
|---|---|
| Compound Name | Ripasudil |
| Canonical SMILES | C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.98 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13165 |
|---|---|
| Drug Name | Ripasudil |
| CAS Number | 223645-67-8 |
| Groups | investigational |
| ATC Codes | S01EX07 S01EA55 |
| Description | Ripasudil, as hydrochloride hydrate (K-115), is a specifc Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor used for the treatment of glaucoma and ocular hypertension. It was first approved for treatment in Japan in September 2014. This medication is available in the form of a 0.... |
Categories: Amides Antiglaucoma Preparations and Miotics Heterocyclic Compounds, Fused-Ring Ophthalmologicals Sensory Organs Sulfones Sulfur Compounds Sympathomimetics in Glaucoma Therapy rho-Associated Kinases, antagonists & inhibitors
Cross-references: BindingDB: 50087135 ChEBI: 136046 CHEMBL3426621 ChemSpider: 8039366 PubChem:9863672 PubChem:347829272 Wikipedia: Ripasudil ZINC: ZINC000003940873
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O75116 | ROCK2 | Homo sapiens | Human | PF25346 PF00069 PF08912 | 7.7 | IC50 | ChEMBL;BindingDB |
| Q13464 | ROCK1 | Homo sapiens | Human | PF25346 PF00069 PF08912 | 7.3 | IC50 | ChEMBL;BindingDB |
| Q16513 | PKN2 | Homo sapiens | Human | PF02185 PF00069 PF00433 | 6.5 | Kd | ChEMBL |
| Q16512 | PKN1 | Homo sapiens | Human | PF02185 PF00069 PF00433 | 6.4 | Kd | ChEMBL |